Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Total Current Liabilities: 2013-2019

Historic Total Current Liabilities for Soleno Therapeutics (SLNO) over the last 5 years, with Sep 2019 value amounting to $3.5 million.

  • Soleno Therapeutics' Total Current Liabilities rose 37.72% to $3.5 million in Q3 2019 from the same period last year, while for Sep 2019 it was $3.5 million, marking a year-over-year increase of 37.72%. This contributed to the annual value of $1.9 million for FY2018, which is 8.31% up from last year.
  • As of Q3 2019, Soleno Therapeutics' Total Current Liabilities stood at $3.5 million, which was up 20.98% from $2.9 million recorded in Q2 2019.
  • In the past 5 years, Soleno Therapeutics' Total Current Liabilities ranged from a high of $13.3 million in Q2 2015 and a low of $1.1 million during Q1 2015.
  • Moreover, its 3-year median value for Total Current Liabilities was $2.1 million (2017), whereas its average is $2.2 million.
  • Per our database at Business Quant, Soleno Therapeutics' Total Current Liabilities spiked by 277.69% in 2015 and then crashed by 85.76% in 2016.
  • Over the past 5 years, Soleno Therapeutics' Total Current Liabilities (Quarterly) stood at $3.2 million in 2015, then crashed by 46.52% to $1.7 million in 2016, then rose by 1.50% to $1.7 million in 2017, then increased by 8.31% to $1.9 million in 2018, then skyrocketed by 37.72% to $3.5 million in 2019.
  • Its last three reported values are $3.5 million in Q3 2019, $2.9 million for Q2 2019, and $2.2 million during Q1 2019.